黄金一代201612
九十九湾---美股ZH1193346修改信息修改分组分享 关停组合
调仓 √ 已关注
1 人关注
46.43%总收益
日
17.37%
月
43.07%
净值
1.4643
总收益排行(美股)
跑赢82.79%组合
美股<...查看全文
矫首遐观2018-01-06 00:24
$Cellular Biomedicine Group, Inc.(CBMG)$ 西比曼目前重点是在布局外包型的GMP生产中心,从全球角度来看,诺华在细胞治疗方面的GMP生产中心准备是最为充分的,其主要的合作伙伴是GE医疗和BD,而西比曼正在快速复制这一路径,通过与GE医疗和赛默飞世尔的深度合作,打造开放型的细胞疗法的GMP生产平...查看全文
资本主义拉美行不通2018-01-02 13:15
$人福医药(SH600079)$ $Cellular Biomedicine Group, Inc.(CBMG)$ 消息不用藏着,最好赶快放出来,早晚藏不住查看全文
智通财经APP获悉,强生(JNJ.US)旗下杨森(Janssen)公司5月3日宣布与Cellular Biomedicine Group(CBMG,西比曼生物科技集团)达成全球合作和许可协议,以开发、生产和商业化下一代嵌合抗原受体T细胞(CAR-T)疗法,用于治疗B细胞恶性肿瘤。 ... 网页链接
2023年04月03日 10:22:19 4月3日,专注于开发创新细胞疗法的生物制药公司西比曼生物科技(Cellular Biomedicine Group,CBMG)今日正式宣布,启动公司旗下异体人源脂肪间充质祖细胞注射液AlloJoin®的III期临床试验。... 网页链接
$Cellular Biomedicine(CBMG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000731 Act: 33 Size: 1 KB 网页链接
$Cellular Biomedicine(CBMG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000732 Act: 33 Size: 1 KB 网页链接
$Cellular Biomedicine(CBMG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000733 Act: 33 Size: 1 KB 网页链接
$Cellular Biomedicine(CBMG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000730 Act: 33 Size: 1 KB 网页链接
$Cellular Biomedicine(CBMG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-026984 Act: 34 Size: 77 KB 网页链接
$Cellular Biomedicine(CBMG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001185185-21-000254 Act: 34 Size: 51 KB 网页链接
$Cellular Biomedicine(CBMG)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000249 Act: 34 Size: 3 KB 网页链接
$Cellular Biomedicine(CBMG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000902664-21-001527 Act: 34 Size: 237 KB 网页链接
$Cellular Biomedicine(CBMG)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001654954-21-001896 Act: 33 Size: 36 KB 网页链接
$Cellular Biomedicine(CBMG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001654954-21-001897 Act: 33 Size: 38 KB 网页链接